% Generated by IEEEtran.bst, version: 1.12 (2007/01/11)
\begin{thebibliography}{10}
\providecommand{\url}[1]{#1}
\csname url@samestyle\endcsname
\providecommand{\newblock}{\relax}
\providecommand{\bibinfo}[2]{#2}
\providecommand{\BIBentrySTDinterwordspacing}{\spaceskip=0pt\relax}
\providecommand{\BIBentryALTinterwordstretchfactor}{4}
\providecommand{\BIBentryALTinterwordspacing}{\spaceskip=\fontdimen2\font plus
\BIBentryALTinterwordstretchfactor\fontdimen3\font minus
  \fontdimen4\font\relax}
\providecommand{\BIBforeignlanguage}[2]{{%
\expandafter\ifx\csname l@#1\endcsname\relax
\typeout{** WARNING: IEEEtran.bst: No hyphenation pattern has been}%
\typeout{** loaded for the language `#1'. Using the pattern for}%
\typeout{** the default language instead.}%
\else
\language=\csname l@#1\endcsname
\fi
#2}}
\providecommand{\BIBdecl}{\relax}
\BIBdecl

\bibitem{alsaab2017pd}
H.~O. Alsaab, S.~Sau, R.~Alzhrani, K.~Tatiparti, K.~Bhise, S.~K. Kashaw, and
  A.~K. Iyer, ``Pd-1 and pd-l1 checkpoint signaling inhibition for cancer
  immunotherapy: mechanism, combinations, and clinical outcome,''
  \emph{Frontiers in pharmacology}, vol.~8, p. 561, 2017.

\bibitem{spencer2016biomarkers}
K.~R. Spencer, J.~Wang, A.~W. Silk, S.~Ganesan, H.~L. Kaufman, and J.~M.
  Mehnert, ``Biomarkers for immunotherapy: current developments and
  challenges,'' \emph{American Society of Clinical Oncology educational book},
  vol.~36, pp. e493--e503, 2016.

\bibitem{ding2019clinicopathological}
X.~Ding, Q.~Chen, Z.~Yang, J.~Li, H.~Zhan, N.~Lu, M.~Chen, Y.~Yang, J.~Wang,
  and D.~Yang, ``Clinicopathological and prognostic value of pd-l1 in
  urothelial carcinoma: a meta-analysis,'' \emph{Cancer management and
  research}, vol.~11, p. 4171, 2019.

\bibitem{zhou2017review}
T.~C. Zhou, A.~I. Sankin, S.~A. Porcelli, D.~S. Perlin, M.~P. Schoenberg, and
  X.~Zang, ``A review of the pd-1/pd-l1 checkpoint in bladder cancer: From
  mediator of immune escape to target for treatment,'' in \emph{Urologic
  Oncology: Seminars and Original Investigations}, vol.~35, no.~1.\hskip 1em
  plus 0.5em minus 0.4em\relax Elsevier, 2017, pp. 14--20.

\bibitem{ferlay2015cancer}
J.~Ferlay, I.~Soerjomataram, R.~Dikshit, S.~Eser, C.~Mathers, M.~Rebelo, D.~M.
  Parkin, D.~Forman, and F.~Bray, ``Cancer incidence and mortality worldwide:
  sources, methods and major patterns in globocan 2012,'' \emph{International
  journal of cancer}, vol. 136, no.~5, pp. E359--E386, 2015.

\bibitem{de2012randomized}
M.~De~Santis, J.~Bellmunt, G.~Mead, J.~M. Kerst, M.~Leahy, P.~Maroto, T.~Gil,
  S.~Marreaud, G.~Daugaard, I.~Skoneczna \emph{et~al.}, ``Randomized phase
  ii/iii trial assessing gemcitabine/carboplatin and
  methotrexate/carboplatin/vinblastine in patients with advanced urothelial
  cancer who are unfit for cisplatin-based chemotherapy: Eortc study 30986,''
  \emph{Journal of clinical oncology}, vol.~30, no.~2, p. 191, 2012.

\bibitem{seront2015molecular}
E.~Seront and J.-P. Machiels, ``Molecular biology and targeted therapies for
  urothelial carcinoma,'' \emph{Cancer treatment reviews}, vol.~41, no.~4, pp.
  341--353, 2015.

\bibitem{powles2018atezolizumab}
T.~Powles, I.~Dur{\'a}n, M.~S. Van Der~Heijden, Y.~Loriot, N.~J. Vogelzang,
  U.~De~Giorgi, S.~Oudard, M.~M. Retz, D.~Castellano, A.~Bamias \emph{et~al.},
  ``Atezolizumab versus chemotherapy in patients with platinum-treated locally
  advanced or metastatic urothelial carcinoma (imvigor211): a multicentre,
  open-label, phase 3 randomised controlled trial,'' \emph{The Lancet}, vol.
  391, no. 10122, pp. 748--757, 2018.

\bibitem{bellmunt2017pembrolizumab}
J.~Bellmunt, R.~De~Wit, D.~J. Vaughn, Y.~Fradet, J.-L. Lee, L.~Fong, N.~J.
  Vogelzang, M.~A. Climent, D.~P. Petrylak, T.~K. Choueiri \emph{et~al.},
  ``Pembrolizumab as second-line therapy for advanced urothelial carcinoma,''
  \emph{New England Journal of Medicine}, vol. 376, no.~11, pp. 1015--1026,
  2017.

\bibitem{sharma2016efficacy}
P.~Sharma, P.~Bono, J.~W. Kim, P.~Spiliopoulou, E.~Calvo, R.~N. Pillai, P.~A.
  Ott, F.~G. De~Braud, M.~A. Morse, D.~T. Le \emph{et~al.}, ``Efficacy and
  safety of nivolumab monotherapy in metastatic urothelial cancer (muc):
  Results from the phase i/ii checkmate 032 study.'' 2016.

\bibitem{massard2016safety}
C.~Massard, M.~S. Gordon, S.~Sharma, S.~Rafii, Z.~A. Wainberg, J.~Luke, T.~J.
  Curiel, G.~Colon-Otero, O.~Hamid, R.~E. Sanborn \emph{et~al.}, ``Safety and
  efficacy of durvalumab (medi4736), an anti--programmed cell death ligand-1
  immune checkpoint inhibitor, in patients with advanced urothelial bladder
  cancer,'' \emph{Journal of Clinical Oncology}, vol.~34, no.~26, p. 3119,
  2016.

\bibitem{apolo2017avelumab}
A.~B. Apolo, J.~R. Infante, A.~Balmanoukian, M.~R. Patel, D.~Wang, K.~Kelly,
  A.~E. Mega, C.~D. Britten, A.~Ravaud, A.~C. Mita \emph{et~al.}, ``Avelumab,
  an anti--programmed death-ligand 1 antibody, in patients with refractory
  metastatic urothelial carcinoma: results from a multicenter, phase ib
  study,'' \emph{Journal of Clinical Oncology}, vol.~35, no.~19, p. 2117, 2017.

\bibitem{banna2019promise}
G.~L. Banna, T.~Oliver, F.~Rundo, U.~Malapelle, F.~Fraggetta, M.~L. Libra, and
  A.~Addeo, ``The promise of digital biopsy for the prediction of tumor
  molecular features and clinical outcomes associated with immunotherapy,''
  \emph{Frontiers in medicine}, vol.~6, p. 172, 2019.

\bibitem{lambin2012radiomics}
P.~Lambin, E.~Rios-Velazquez, R.~Leijenaar, S.~Carvalho, R.~G. van Stiphout,
  P.~Granton, C.~M. Zegers, R.~Gillies, R.~Boellard, A.~Dekker \emph{et~al.},
  ``Radiomics: Extracting more information from medical images using advanced
  feature analysis,'' \emph{European Journal of Cancer}, vol.~48, no.~4, pp.
  441--446, 2012.

\bibitem{wang2015prediction}
G.~Wang, K.-M. Lam, Z.~Deng, and K.-S. Choi, ``Prediction of mortality after
  radical cystectomy for bladder cancer by machine learning techniques,''
  \emph{Computers in biology and medicine}, vol.~63, pp. 124--132, 2015.

\bibitem{garapati2017urinary}
S.~S. Garapati, L.~Hadjiiski, K.~H. Cha, H.-P. Chan, E.~M. Caoili, R.~H. Cohan,
  A.~Weizer, A.~Alva, C.~Paramagul, J.~Wei \emph{et~al.}, ``Urinary bladder
  cancer staging in ct urography using machine learning,'' \emph{Medical
  physics}, vol.~44, no.~11, pp. 5814--5823, 2017.

\bibitem{hasnain2019machine}
Z.~Hasnain, J.~Mason, K.~Gill, G.~Miranda, I.~S. Gill, P.~Kuhn, and P.~K.
  Newton, ``Machine learning models for predicting post-cystectomy recurrence
  and survival in bladder cancer patients,'' \emph{PloS one}, vol.~14, no.~2,
  2019.

\bibitem{cha2016urinary}
K.~H. Cha, L.~Hadjiiski, R.~K. Samala, H.-P. Chan, E.~M. Caoili, and R.~H.
  Cohan, ``Urinary bladder segmentation in ct urography using deep-learning
  convolutional neural network and level sets,'' \emph{Medical physics},
  vol.~43, no.~4, pp. 1882--1896, 2016.

\bibitem{gordon2017segmentation}
M.~Gordon, L.~Hadjiiski, K.~Cha, H.-P. Chan, R.~Samala, R.~H. Cohan, and E.~M.
  Caoili, ``Segmentation of inner and outer bladder wall using deep-learning
  convolutional neural network in ct urography,'' in \emph{Medical Imaging
  2017: Computer-Aided Diagnosis}, vol. 10134.\hskip 1em plus 0.5em minus
  0.4em\relax International Society for Optics and Photonics, 2017, p. 1013402.

\bibitem{ma20192d}
X.~Ma, L.~Hadjiiski, J.~Wei, H.-P. Chan, K.~Cha, R.~H. Cohan, E.~M. Caoili,
  R.~Samala, C.~Zhou, and Y.~Lu, ``2d and 3d bladder segmentation using
  u-net-based deep-learning,'' in \emph{Medical Imaging 2019: Computer-Aided
  Diagnosis}, vol. 10950.\hskip 1em plus 0.5em minus 0.4em\relax International
  Society for Optics and Photonics, 2019, p. 109500Y.

\bibitem{shkolyar2019augmented}
E.~Shkolyar, X.~Jia, T.~C. Chang, D.~Trivedi, K.~E. Mach, M.~Q.-H. Meng,
  L.~Xing, and J.~C. Liao, ``Augmented bladder tumor detection using deep
  learning,'' \emph{European urology}, vol.~76, no.~6, pp. 714--718, 2019.

\bibitem{wu2019deep}
E.~Wu, L.~M. Hadjiiski, R.~K. Samala, H.-P. Chan, K.~H. Cha, C.~Richter, R.~H.
  Cohan, E.~M. Caoili, C.~Paramagul, A.~Alva \emph{et~al.}, ``Deep learning
  approach for assessment of bladder cancer treatment response,''
  \emph{Tomography}, vol.~5, no.~1, p. 201, 2019.

\bibitem{krizhevsky2012imagenet}
A.~Krizhevsky, I.~Sutskever, and G.~E. Hinton, ``Imagenet classification with
  deep convolutional neural networks,'' in \emph{Advances in neural information
  processing systems}, 2012, pp. 1097--1105.

\bibitem{cha2017bladder}
K.~H. Cha, L.~Hadjiiski, H.-P. Chan, A.~Z. Weizer, A.~Alva, R.~H. Cohan, E.~M.
  Caoili, C.~Paramagul, and R.~K. Samala, ``Bladder cancer treatment response
  assessment in ct using radiomics with deep-learning,'' \emph{Scientific
  reports}, vol.~7, no.~1, pp. 1--12, 2017.

\bibitem{rundo2019advanced}
F.~Rundo, C.~Spampinato, G.~L. Banna, and S.~Conoci, ``Advanced deep learning
  embedded motion radiomics pipeline for predicting anti-pd-1/pd-l1
  immunotherapy response in the treatment of bladder cancer: Preliminary
  results,'' \emph{Electronics}, vol.~8, no.~10, p. 1134, 2019.

\bibitem{eisenhauer2009new}
E.~A. Eisenhauer, P.~Therasse, J.~Bogaerts, L.~H. Schwartz, D.~Sargent,
  R.~Ford, J.~Dancey, S.~Arbuck, S.~Gwyther, M.~Mooney \emph{et~al.}, ``New
  response evaluation criteria in solid tumours: revised recist guideline
  (version 1.1),'' \emph{European journal of cancer}, vol.~45, no.~2, pp.
  228--247, 2009.

\bibitem{chua1988cellular}
L.~O. Chua and L.~Yang, ``Cellular neural networks: Theory,'' \emph{IEEE
  Transactions on circuits and systems}, vol.~35, no.~10, pp. 1257--1272, 1988.

\bibitem{arena1996dynamics}
P.~Arena, S.~Baglio, L.~Fortuna, and G.~Manganaro, ``Dynamics of state
  controlled cnns,'' in \emph{1996 IEEE International Symposium on Circuits and
  Systems. Circuits and Systems Connecting the World. ISCAS 96}, vol.~3.\hskip
  1em plus 0.5em minus 0.4em\relax IEEE, 1996, pp. 56--59.

\bibitem{chua1992cnn}
L.~O. Chua and T.~Roska, ``The cnn universal machine. i. the architecture,'' in
  \emph{CNNA'92 Proceedings Second International Workshop on Cellular Neural
  Networks and Their Applications}.\hskip 1em plus 0.5em minus 0.4em\relax
  IEEE, 1992, pp. 1--10.

\bibitem{fortuna2001cellular}
L.~Fortuna, P.~Arena, D.~Balya, and A.~Zarandy, ``Cellular neural networks: a
  paradigm for nonlinear spatio-temporal processing,'' \emph{IEEE Circuits and
  Systems magazine}, vol.~1, no.~4, pp. 6--21, 2001.

\bibitem{207503}
T.~{Roska} and L.~O. {Chua}, ``Cellular neural networks with nonlinear and
  delay-type template elements,'' in \emph{IEEE International Workshop on
  Cellular Neural Networks and their Applications}, 1990, pp. 12--25.

\bibitem{lee1996color}
C.-C. Lee and J.~P. de~Gyvez, ``Color image processing in a cellular
  neural-network environment,'' \emph{IEEE Transactions on neural networks},
  vol.~7, no.~5, pp. 1086--1098, 1996.

\bibitem{LIU201711}
\BIBentryALTinterwordspacing
W.~Liu, Z.~Wang, X.~Liu, N.~Zeng, Y.~Liu, and F.~E. Alsaadi, ``A survey of deep
  neural network architectures and their applications,'' \emph{Neurocomputing},
  vol. 234, pp. 11 -- 26, 2017. [Online]. Available:
  \url{http://www.sciencedirect.com/science/article/pii/S0925231216315533}
\BIBentrySTDinterwordspacing

\bibitem{zoph2017learning}
B.~Zoph, V.~Vasudevan, J.~Shlens, and Q.~V. Le, ``Learning transferable
  architectures for scalable image recognition,'' 2017.

\end{thebibliography}
